RDHL has been in the news 500% more than usual
Sep 10, 2024, 2:32 PM
-17.82%
What does RDHL do
RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
RDHL has been in the news recently: LakeShore Biopharma will hold an extraordinary general meeting on September 27, 2024, to approve a 10-to-1 share consolidation in order to comply with Nasdaq regulations and to discuss compliance with the minimum bid price requirement. Additionally, Connect Biopharma Holdings Limited will present at the Cantor Fitzgerald Global Healthcare Conference from September 17-19, 2024, with a key presentation scheduled for September 19 at 9:10 AM ET.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.